[Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use*; D011984:Sensory Receptor Cells / Q000187:drug effects; D013565:Sympatholytics / Q000627:therapeutic use*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D013565:Sympatholytics; D011433:Propranolol; D004837:Epinephrine
Antyarytmiczne działanie DL-propranololu, D-proprnololu i I.C.I. 50 172 w doswiadczalnym zawale serca u psa.